Avacincaptad pegol 2 mg stands out as the most effective and safest complement inhibitor for reducing geographic atrophy lesion size in patients with AMD, compared to other treatments like pegcetacoplan, which carries a...

Early cataract is a rare but significant complication in children and adolescents with newly diagnosed type 1 diabetes mellitus (T1DM), according to a study. Prompt stabilization of blood glucose levels through intensive insulin...

Transient receptor potential (TRP) channel modulators, specifically TRPV1 antagonists and TRPM8 agonists, show promise as effective and safe treatments for dry eye disease, according to a study. Researchers conducted a comprehensive review of...

Faricimab therapy for neovascular age-related macular degeneration and diabetic macular edema has a low incidence of intraocular inflammation adverse events, which are generally mild and have a favorable prognosis, according to a study....